Efficacy and safety of PD-1/PD-L1 inhibitors in the treatment of recurrent and refractory ovarian cancer: A systematic review and a meta-analysis

Efficacy and safety of PD-1/PD-L1 inhibitors in the treatment of recurrent and refractory ovarian cancer: A systematic review and a meta-analysis

Objective: To explore the efficacy and safety of PD-1/PD-L1 inhibitors in treating recurrent/refractory ovarian cancer (OC).Methods: The online databases, including PubMed, Embase and Cochrane Library, were searched for relevant literatures on exploring the efficacy and safety of PD-1/PD-L1 inhibito...

Full description

Bibliographic Details
Main Authors: Siyuan Zeng, Daju Liu, Yongai Yu, Lei Zou, Xianyu Jin, Bing Liu, Lifeng Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Pharmacology
Subjects:
recurrent/refractory ovarian cancer
PD-1/PD-L1 inhibitors
immunotherapy
immunocheckpoint inhibitors
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1111061/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1111061/full

Similar Items